Brachytherapy for gynecological cancers will be studied retrospectively.
Study Type
OBSERVATIONAL
Enrollment
300
Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
RECRUITINGOverall survival rate
the percentage of participants in the group who survives
Time frame: 5-year
Progression-free survival rate
the percentage of participants in the group whose disease is likely to remain stable
Time frame: 5-year
Side effects
side effects associated with treatment
Time frame: 5-year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.